0

Allergan Plc (AGN) – Financial and Strategic SWOT Analysis Review

Publisher Name :
Date: 15-Mar-2017
No. of pages: 75

Allergan Plc (AGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Allergan Plc (Allergan) is a specialty pharmaceutical company that develops and sells branded pharmaceuticals, biosimilar and over-the-counter (OTC) pharmaceutical products. It offers products in the areas of eye care, medical aesthetics, dermatology, central nervous system, gastroenterology, women’s health, urology and anti-infective therapeutic categories. The company sells its products primarily to retailers, drug wholesalers and distributors, including national retail drug and food store chains, mail order retailers, hospitals, clinics, government agencies and managed healthcare providers such as health maintenance organizations and other institutions. It has operations in several countries across the world including the US, Canada, China, India, and other high growth markets in Europe, Southeast Asia, Middle East and Latin America. Allergan is headquartered in Dublin, Ireland.

Allergan Plc Key Recent Developments

Mar 03, 2017: Allergan Presents Data From 21 Abstracts At The 2017 American Academy Of Dermatology Meeting In Orlando, FL
Feb 27, 2017: Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan
Feb 08, 2017: Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016
Jan 23, 2017: Allergan Continues Commitment to Future of Headache Medicine with Educational Grants for Young Neurologists and Research Scientists
Jan 05, 2017: Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Allergan Plc - Key Facts 6
Allergan Plc - Key Employees 7
Allergan Plc - Key Employee Biographies 8
Allergan Plc - Major Products and Services 10
Allergan Plc - Pharmaceutical Pipeline Products Data 12
Allergan Plc, Pipeline Products by Therapy Area 12
Allergan Plc, Pipeline Products by Development Phase 13
Allergan Plc - History 14
Allergan Plc - Company Statement 27
Allergan Plc - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Section 2 - Company Analysis 37
Allergan Plc - Business Description 37
Allergan Plc - Corporate Strategy 38
Allergan Plc - SWOT Analysis 39
SWOT Analysis - Overview 39
Allergan Plc - Strengths 39
Allergan Plc - Weaknesses 40
Allergan Plc - Opportunities 41
Allergan Plc - Threats 43
Allergan Plc - Key Competitors 44
Section 3 - Company Financial Ratios 45
Financial Ratios - Capital Market Ratios 45
Financial Ratios - Annual Ratios 46
Performance Chart 48
Financial Performance 48
Financial Ratios - Interim Ratios 49
Financial Ratios - Ratio Charts 50
Section 4 - Company's Lifesciences Financial Deals and Alliances 51
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 51
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 52
Allergan Plc, Recent Deals Summary 53
Section 5 - Company's Recent Developments 54
Mar 03, 2017: Allergan Presents Data From 21 Abstracts At The 2017 American Academy Of Dermatology Meeting In Orlando, FL 54
Feb 27, 2017: Lisa DeFrancesco, Vice President of Investor Relations, to Leave Allergan 56
Feb 08, 2017: Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016 57
Jan 23, 2017: Allergan Continues Commitment to Future of Headache Medicine with Educational Grants for Young Neurologists and Research Scientists 61
Jan 05, 2017: Allergan to Present at Goldman Sachs Healthcare CEOs Unscripted Conference and Provides Preliminary Comments on 2017 Outlook 62
Nov 14, 2016: Adriane M. Brown to Join Allergan Board of Directors 63
Nov 02, 2016: Allergan Reports Third Quarter 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion; Announces Accelerated Share Repurchase, Initiation of Cash Dividend 64
Oct 29, 2016: Data Presented at IDWeek Highlight Risk Factors for Carbapenem Resistance Among Patients Hospitalized for Serious Infections 68
Oct 26, 2016: Allergan Announces Changes to Board Leadership 69
Oct 16, 2016: Allergan Demonstrates Ongoing Commitment to Irritable Bowel Syndrome (IBS) with Development of IBS CounSEL 70
Section 6 - Appendix 71
Methodology 71
Ratio Definitions 71
About GlobalData 75
Contact Us 75
Disclaimer 75

List of Tables
Allergan Plc, Key Facts 6
Allergan Plc, Key Employees 7
Allergan Plc, Key Employee Biographies 8
Allergan Plc, Major Products and Services 10
Allergan Plc, Number of Pipeline Products by Therapy Area 12
Allergan Plc, Number of Pipeline Products by Development Stage 13
Allergan Plc, History 14
Allergan Plc, Other Locations 28
Allergan Plc, Subsidiaries 28
Allergan Plc, Key Competitors 44
Allergan Plc, Ratios based on current share price 45
Allergan Plc, Annual Ratios 46
Allergan Plc (Cont...1), Annual Ratios 47
Allergan Plc, Interim Ratios 49
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 51
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 52
Allergan Plc, Recent Deals Summary 53
Currency Codes 71
Capital Market Ratios 71
Equity Ratios 72
Profitability Ratios 72
Cost Ratios 73
Liquidity Ratios 73
Leverage Ratios 73
Efficiency Ratios 74

List of Figures
Allergan Plc, Pipeline Products by Therapy Area 12
Allergan Plc, Pipeline Products by Development Phase 13
Allergan Plc, Performance Chart (2012 - 2016) 48
Allergan Plc, Ratio Charts 50
Allergan Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 51
Allergan Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 52

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2017 RnR Company Profiles. All rights reserved.